Using human cancer cell lines expressing p53 with various lysine to arginine mutations, these studies indicate that K120R, K164R as well as K120/164R double mutations partially impaired the p53-dependent functions (Sykes et al., 2006; Tang et al., 2006; Tang et al., 2008). The gene discussed is TP53; the disease is cancer.